Clinical Trials for Unresectable HER2-Low Breast Carcinoma

Find clinical trials for unresectable her2-low breast carcinoma. Discover research opportunities and treatment options in your area.

1 Active Trial Found

Showing 1 trial on this page

Page 1 of 1

Testing the Safety of the Combination of Anti-Cancer Drugs CX-5461 (Pidnarulex) and Trastuzumab Deruxtecan (T-DXd) for Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Solid Tumors and Breast Cancer

NCT ID: NCT07137416

This clinical trial is studying a new combination of two anti-cancer drugs, called Pidnarulex and trastuzumab deruxtecan, to see if it is safe and what dose works best for treating certain types of...

Not yet recruiting

Phase: PHASE1 Type: interventional

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions